Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call showed mixed signals: strong performance in EMEA, but declining sales in the Americas. The Q&A revealed management's confidence in sustaining growth, but also highlighted uncertainties like tariffs and margin pressures. The company's strategic focus on cost savings and advanced products is positive, but vague responses on sequential growth and tariffs introduce caution. Overall, the balanced mix of positive and negative factors suggests a neutral impact on the stock price.
Net Sales $483 million, a 4% increase from the prior year. Organic volumes increased 2%, driven by new business wins of approximately 5% and continued strength in the Asia/Pacific segment. Acquisitions contributed an additional 6% to sales. Selling price and product mix were 4% lower than the prior year, approximately 2/3 of which stems from product, service, and geographic mix.
Gross Margins 36%, compared to 36.4% in the first quarter of 2025. Declined compared to the near record levels in the second quarter of 2024, primarily due to higher raw material and manufacturing costs and the impact of geographic and product mix.
Adjusted EBITDA $75.5 million in the second quarter, with adjusted EBITDA margins of 15.6%. This reflects the combination of higher sales, lower gross margins, and disciplined cost management. Increased approximately $6 million sequentially.
Operating Cash Flow $42 million in the second quarter. Cash conversion was at the low end of the targeted range due to higher restructuring costs and lower year-over-year operating performance.
Asia/Pacific Segment Sales Sales increased 20% year-over-year. Organic sales and volumes increased approximately 7% sequentially. Segment earnings declined approximately $2 million compared to the prior year but increased sequentially. Segment margins declined compared to both periods, reflecting higher raw material and manufacturing costs as well as product and geographic mix.
EMEA Segment Sales Net sales grew compared to the prior year and prior quarter. Organic volumes increased 4% in the region sequentially, driven by double-digit growth in the portfolio of advanced and operating solutions. Segment earnings in EMEA increased sequentially driven by higher sales and stable margins despite higher raw material costs.
Americas Segment Sales Net sales declined 1% year-over-year. Volumes declined 2%, whereas price/mix was slightly positive. Organic volumes grew 2% sequentially, driven by growth in metalworking and advanced solutions, despite a modest contraction in end markets. Segment earnings declined by $5 million compared to the prior year, driven by lower sales and segment margins.
Non-GAAP Diluted Earnings Per Share $1.71 in the second quarter, excluding noncash goodwill impairment charge and restructuring charge.
Capital Expenditures Approximately $8 million in the second quarter, reflecting the construction of a new facility in China. Moderated expectation of CapEx spending in 2025 to 2% to 3% of sales due to the timing of ongoing projects.
Net Debt $735 million at quarter-end. Net leverage ratio increased to 2.6x trailing 12 months adjusted EBITDA, reflecting the Dipsol acquisition.
FLUID INTELLIGENCE initiative: Focus on developing breakthrough sensor technology, digitized services, and automation to enhance customer outcomes.
Advanced solutions portfolio: Volumes increased by double-digit percentage year-over-year, showcasing strong growth.
Asia/Pacific growth: Achieved organic growth in 7 of the last 8 quarters, driven by new business wins and cross-selling in China, India, and Southeast Asia.
Dipsol acquisition: Integration of Dipsol's technology and capabilities is expected to contribute to growth, with a new facility in China set to commercialize in the second half of 2026.
Cost savings program: Realized $15 million in savings from a $20 million cost program in 2025, with an additional $20 million in run-rate savings expected by the end of 2026.
Facility closure: Closed one facility in the Americas network and considering further asset consolidation to improve operational efficiency.
Capital allocation strategy: Repurchased $33 million in shares, approved a 5% dividend increase, and completed two acquisitions to support growth.
Local-for-local strategy: Focused on solidifying presence in Asia/Pacific with localized manufacturing and operations.
Macroeconomic Pressures: Sustained macroeconomic pressures are impacting demand and geographic/product mix, creating uncertainty in market conditions.
Tariffs: Uncertainty created by tariffs is negatively affecting demand, geographic, and product mix, as well as increasing raw material and manufacturing costs.
Raw Material Costs: Higher raw material and manufacturing costs are pressuring gross margins and segment profitability, particularly in the Americas and EMEA regions.
Geopolitical Events: Persistent market volatility and geopolitical events in the EMEA region have led to a noncash goodwill impairment charge and increased cost of capital.
End Market Softness: End market softness is expected to persist through the second half of 2025, impacting revenue and earnings.
Cost Structure Challenges: Efforts to reduce complexity and improve cost structure include facility closures and potential asset consolidations, which may disrupt operations in the short term.
Debt and Leverage: Net debt increased to $735 million, with a net leverage ratio of 2.6x trailing 12 months adjusted EBITDA, reflecting acquisition-related funding.
Revenue and Earnings Outlook: The company forecasts revenue and earnings for the second half of 2025 to be in the range of 2024 levels, based on current market visibility and the execution of additional cost actions.
Market Conditions: The company expects end market softness experienced in the first half of 2025 to persist through the second half of the year, influenced by tariffs and significant uncertainty.
Growth Expectations: The company anticipates above-market growth in 2025, in line with its long-term annual expectation of 2% to 4%, supported by a healthy pipeline of product trials and new business conversions.
Cost Savings Initiatives: The company is initiating cost actions expected to deliver approximately $20 million of additional run rate savings by the end of 2026, with $5 million to $8 million of incremental in-year savings in the second half of 2025.
Asia/Pacific Growth: The company expects further contributions from the integration of Dipsol's technology and capabilities, as well as the commercialization of a new facility in China in the second half of 2026, supporting its local-for-local strategy in the region.
Capital Expenditures: Capital expenditures for 2025 are expected to be 2% to 3% of sales, slightly moderated from the previous expectation of 2.5% to 3.5% of sales, due to the timing of ongoing projects.
Dividend Increase: The Board approved a 5% increase to the cash dividend, marking the 16th consecutive annual increase.
Share Repurchase: The company repurchased $33 million worth of shares during the second quarter of 2025. Approximately $68 million remains on the current share repurchase authorization.
The earnings call summary and Q&A highlight stable but modest growth expectations, with positive contributions from the Asia Pacific region and new acquisitions. However, the company's guidance for revenue and earnings to remain at 2024 levels, coupled with market softness, tempers enthusiasm. The lack of clear guidance on robotics and additive manufacturing adds uncertainty. While shareholder returns and cost savings initiatives are positive, these factors balance out, resulting in a neutral sentiment.
The earnings call showed mixed signals: strong performance in EMEA, but declining sales in the Americas. The Q&A revealed management's confidence in sustaining growth, but also highlighted uncertainties like tariffs and margin pressures. The company's strategic focus on cost savings and advanced products is positive, but vague responses on sequential growth and tariffs introduce caution. Overall, the balanced mix of positive and negative factors suggests a neutral impact on the stock price.
The earnings call presents a mixed picture: declining net sales and EBITDA suggest challenges, but cost management and gross margin improvements are positives. The Q&A indicates some uncertainty around tariffs and market volatility, but management's ability to mitigate input costs is reassuring. The lack of clear guidance on tariffs and the modest EBITDA outlook tempers enthusiasm. Overall, the sentiment is neutral, as the positive aspects balance out the negatives, and there is no strong catalyst for significant stock movement.
The earnings call reveals mixed signals: a 6% decline in net sales and a 7% drop in adjusted EBITDA suggest challenges, but a 4% increase in non-GAAP EPS and a 6.6% dividend increase reflect some positives. The Q&A highlights ongoing market softness and potential revenue impacts from factory shutdowns, yet also mentions organic growth in Asia and new business wins. The lack of specific guidance for 2025 adds uncertainty. Overall, the balance of positive and negative factors suggests a neutral stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.